We are monitoring the impact of COVID-19 on Europe Thyroid Cancer Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 2169
Share on
Share on

Europe Thyroid Cancer Market Research Report – Segmented By Treatment (surgery, Iodine Therapy, External Radiotherapy, Thyroxin Treatment, Chemotherapy, Drugs) By End User (Hospital, Oncology Centers, Hospital Pharmacies And Retail Pharmacies.) And By Country (France, Germany, Italy, Spain and UK) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: August, 2019
ID: 2169
Pages: 140

Europe Thyroid Cancer Market Size & Growth (2019-2024):

As per our report, Europe market for Thyroid cancer was USD 75.35 million in 2019 and is expected to grow at a CAGR of 23% to reach USD 212.14 million by 2024 during the forecast period 2019-2024.

Thyroid tumor is comparatively less than many other cancers. In the United States, it is assessed that in 2016 around 64,000 new patients are reported to have thyroid disease, contrasted with more than 240,000 patients with breast tumors and 135,000 patients with colon malignancy. Be that as it may, less than 2000 patients pass on of thyroid malignancy every year. In 2013, the most recent year for which measurements are accessible, more than 630,000 patients were living with thyroid growth in the United States.

Generally, Thyroid tumor is treatable without any difficulties and is basically cured with surgery. Notwithstanding when thyroid malignancy is more cutting-edge, successful treatment is accessible for the most widely recognized types of thyroid tumors. Despite the fact that the determination of tumor is terrifying, the guess for most patients with papillary and follicular thyroid growth is generally more.

Europe Thyroid Cancer Market segmented and sub-segmented into the following categories.

  • By Treatment: Surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs.
  • By Drug: Levothyroxine and Radioiodine
  • By End User: Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Notable operating in the Europe Thyroid Cancer Market profiled in this report are Baxter International Inc., Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co, Abbott laboratories, Teva parenteral medicines Inc., App pharmaceuticals LLC and Jerome Stevens Pharmaceuticals Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Surgery     

                                5.1.3 Iodine Theraphy   

                                5.1.4 External radiotherapy        

                                5.1.5 Thyroxine treatment          

                                5.1.6  chemotherapy     

                                5.1.7 Drugs         

                                5.1.8  Y-o-Y Growth Analysis, By Treatment         

                                5.1.9  Market Attractiveness Analysis, By Treatment       

                                5.1.10 Market Share Analysis, By Treatment       

                5.2 End User      

                                5.2.1 Introduction           

                                5.2.2 Hospital    

                                5.2.3 Oncology centers 

                                5.2.4 Hospital Pharmacies            

                                5.2.5 Retail Pharmacies 

                                5.2.6 Y-o-Y Growth Analysis, By End User             

                                5.2.7 Market Attractiveness Analysis, By End User           

                                5.2.8 Market Share Analysis, By End User             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                                6.1.3.3 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                                6.1.4.3 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                                                6.1.5.3 By End User

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Baxter International Inc                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Mylan pharmaceuticals Inc                  

                8.3 Alara Pharmaceutical Corporation                    

                8.4  Bristol Myers co                       

                8.5  Abbott laboratories                               

                8.6 Teva parenteral medicines Inc                           

                8.7 App pharmaceuticals llc                         

                8.8  Jerome Stevens Pharmaceuticals Inc                             

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  2. Europe Surgery Market By Region, From 2019-2024 ( USD Million )
  3. Europe Iodine Theraphy Market By Region, From 2019-2024 ( USD Million )
  4. Europe External radiotherapy Market By Region, From 2019-2024 ( USD Million )
  5. Europe Thyroxine treatment Market By Region, From 2019-2024 ( USD Million )
  6. Europe chemotherapy Market By Region, From 2019-2024 ( USD Million )
  7. Europe Drugs Market By Region, From 2019-2024 ( USD Million )
  8. Europe Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  9. Europe Hospitals Market By Region, From 2019-2024 ( USD Million )
  10. Europe Oncology Centers Market By Region, From 2019-2024 ( USD Million )
  11. Europe Hospital Pharmacies Market By Region, From 2019-2024 ( USD Million )
  12. Europe Retail Pharmacies Market By Region, From 2019-2024 ( USD Million )
  13. U.K. Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  14. U.K. Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  15. Germany Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  16. Germany Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  17. France Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  18. France Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  19. Italy Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  20. Italy Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )
  21. Spain Thyroid Cancer Market By Treatment, From 2019-2024 ( USD Million )
  22. Spain Thyroid Cancer Market By  End User, From 2019-2024 ( USD Million )

 

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample